Micellar Paclitaxel to Treat Severe Psoriasis

NCT00006276 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Micellar Paclitaxel

Sponsor

National Cancer Institute (NCI)